Brief: Genscript Biotech Posts HY Adjusted Net Loss Of About US$134.3 Million
Aug 23 (Reuters) - Genscript Biotech Corp 1548.HK :
* HY ADJUSTED NET LOSS WAS ABOUT US$134.3 MILLION VERSUS
LOSS OF
US$68.7 MILLION
* HY REVENUE US$229.6 MILLION, INCREASE OF 38.0%
Source text for Eikon: ID:nHKS9ZqkkB
Further company coverage: 1548.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale